Advanced search
Publication Cover
Clinical Toxicology Volume 57, 2019 - Issue 7
Submit an article Journal homepage
498
Views
11
CrossRef citations to date
0
Altmetric
Short Communication

Acute toxicity following analytically confirmed use of the novel psychoactive substance (NPS) methiopropamine. A report from the Identification of Novel psychoActive substances (IONA) study

Joanna C. WhiteClinical Toxicology, Guy’s and St Thomas’ NHS Foundation Trust, London, UK; View further author information
,
David M. WoodClinical Toxicology, Guy’s and St Thomas’ NHS Foundation Trust, London, UK; ;Faculty of Life Sciences and Medicine, King’s College London, London, UK; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-7826-7237View further author information
ORCID Icon,
Simon L. HillClinical Toxicology, Newcastle Hospitals NHS Foundation Trust, Newcastle, UK; View further author information
,
Michael EddlestonClinical Toxicology, Royal Infirmary of Edinburgh, Edinburgh, UK; ORCID Iconhttp://orcid.org/0000-0002-6857-3441View further author information
ORCID Icon,
Jane OfficerScottish Police Authority, SPA Forensic Services, Edinburgh, UK; View further author information
,
Paul I. DarganClinical Toxicology, Guy’s and St Thomas’ NHS Foundation Trust, London, UK; ;Faculty of Life Sciences and Medicine, King’s College London, London, UK; View further author information
,
Michael DunnNIHR Health Protection Research Unit for Chemical Threats and Hazards, Newcastle University, Newcastle, UKView further author information
&
Simon H.L. ThomasClinical Toxicology, Newcastle Hospitals NHS Foundation Trust, Newcastle, UK; ;NIHR Health Protection Research Unit for Chemical Threats and Hazards, Newcastle University, Newcastle, UKView further author information
 show all
Pages 663-667 | Received 13 Aug 2018, Accepted 14 Oct 2018, Published online: 24 Jan 2019

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Benjamin Crulli, Alison M. Dines, Georgina Blanco, Isabelle Giraudon, Florian Eyer, Matthias E. Liechti, Òscar Miró, Knut E. Hovda, Fridtjof Heyerdahl, Christopher Yates, Odd Martin Vallersnes, David M. Wood, Paul I. Dargan, Lukasz Anand, Kurt Anseeuw, Robertas Badaras, Jeffrey Bonnici, Miran Brvar, Blazena Caganova, Feriyde Calýskan, Alessandro Ceschi, Karam Chamoun, Laurence Daveloose, Miguel Galicia, Stefanie Geith, Ketevan Gorozia, Damjan Grenc, Femke Gresnigt, Laura Hondebrink, Gesche Jürgens, Jutta Konstari, Soso Kutubidze, Gabija Laubner, Evangelia Liakoni, Viesturs Liguts, Cathelijne Lyphout, Thomas MacMahon, Bruno Mégarbane, Adrian Moughty, Gabriela Viorela Nitescu, Roberta Noseda, Niall O'Connor, Raido Paasma, Juan Ortega Perez, Marius Perminas, Per Sverre Persett, Kristiina Põld, Jordi Puiguriguer, Julia Radenkova-Saeva, Jan Rulisek, Yasmin Schmid, Irene Scholz, Roberts Stašinskis, Jonas Surkus, Wesley van den Busken, Irma van den Hengel-Koot, Federico Vigorita, Wojciech Waldmanm, William Stephen Waring & Sergej Zacharov. (2022) Novel psychoactive substances-related presentations to the emergency departments of the European drug emergencies network plus (Euro-DEN plus) over the six-year period 2014–2019. Clinical Toxicology 60:12, pages 1318-1327.
Read now
Michael E. Mullins. (2020) Fentanyl, Inc.. Clinical Toxicology 58:12, pages 1350-1350.
Read now

Articles from other publishers (9)

Rebekka Syrjanen, Jennifer L. Schumann, Tom Lyons, Ginny McKinnon, Sarah E. Hodgson, Rachelle Abouchedid, Dimitri Gerostamoulos, Zeff Koutsogiannis, John Fitzgerald & Shaun L. Greene. (2023) A risk-based approach to community illicit drug toxicosurveillance: operationalisation of the Emerging Drugs Network of Australia – Victoria (EDNAV) project. International Journal of Drug Policy 122, pages 104251.
Crossref
Chinaza Godswill Awuchi, Maduabuchi Patrick Aja, Nancy Bonareri Mitaki, Sonia Morya, Ikechukwu O. Amagwula, Chinelo Kate Echeta & Victory S. Igwe. (2023) New Psychoactive Substances: Major Groups, Laboratory Testing Challenges, Public Health Concerns, and Community-Based Solutions. Journal of Chemistry 2023, pages 1-36.
Crossref
Jennifer L. Smith, David McCutcheon, Courtney Weber, Jessamine Soderstrom, Jonathon Burcham & Daniel M. Fatovich. (2022) ‘Trial by fire’: An online survey exploring confidence of junior doctors in managing toxicology presentations to the emergency department. Drug and Alcohol Review 41:7, pages 1554-1564.
Crossref
Sam Craft, Michael Dunn, Dan Vidler, Jane Officer, Ian S. Blagbrough, Christopher R. Pudney, Graeme Henderson, Ahmed Abouzeid, Paul I. Dargan, Michael Eddleston, Jamie Cooper, Simon L. Hill, Clair Roper, Tom P. Freeman & Simon H. L. Thomas. (2022) Trends in hospital presentations following analytically confirmed synthetic cannabinoid receptor agonist exposure before and after implementation of the 2016 UK Psychoactive Substances Act. Addiction.
Crossref
Jennifer L Smith, Jessamine Soderstrom, Andrew Dawson, Sam Alfred, Shaun Greene, Katherine Isoardi, David McCutcheon, Francois Oosthuizen, Nadine Ezard, Jonathon Burcham & Daniel M Fatovich. (2021) The Emerging Drugs Network of Australia: A toxicosurveillance system of illicit and emerging drugs in the emergency department. Emergency Medicine Australasia 34:1, pages 58-64.
Crossref
John R.H. Archer. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances 131 156 .
Kelly J. Stockdale, Michelle Addison & Georgia Ramm. 2022. Drugs, Identity and Stigma. Drugs, Identity and Stigma 147 172 .
Federica Foti, Sabrine Bilel, Micaela Tirri, Raffaella Arfè, Federica Boccuto, Tatiana Bernardi, Giovanni Serpelloni, Fabio De-Giorgio & Matteo Marti. (2021) Low-normal doses of methiopropamine induce aggressive behaviour in mice. Psychopharmacology 238:7, pages 1847-1856.
Crossref
Dino Luethi & Matthias E. Liechti. (2020) Designer drugs: mechanism of action and adverse effects. Archives of Toxicology 94:4, pages 1085-1133.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.